Hyperthermic Intraperitoneal Chemotherapy With Paclitaxel in Advanced Ovarian Cancer

Exclusion Criteria

• •Patients with unresectable tumor or incomplete cytoreduction.
• •Contraindications for treatment with paclitaxel: patients with severe hypersensitivity to paclitaxel or any of the excipients,pregnancy or lactation and patients with baseline neutrophil count \<1.500/mm3 (\<1.000/mm3 for patients with Kaposi sarcoma). Paclitaxel is also contraindicated in patients who have concurrent and severe infections.
• •Extra-abdominal metastases or unresectable liver metastases
• •Presence of other malignant tumor disease.
• •Multisegmental complete bowel obstruction.
• •Patients with severe medical problems that will preclude compliance with the study or with an unacceptable risk
• •Patients who refuse treatment or consent to participate in study